Intrapharm laboratories have announced that a full supply of Inhixa (Enoxaparin Sodium) to the U.K. market is guaranteed.  In recent months, the Low Molecular Weight Heparin market (LMWH) has seen considerable supply disruption and volatility, which has placed hospitals and pharmacies in the position of managing scarce supplies.

 

Intrapharm launched Inhixa (Enoxaparin Sodium), the first biosimilar of Enoxaparin Sodium, indicated for VTE prophylaxis and DVT treatment to the U.K. market in September 2017

 

Inhixa (Enoxaparin Sodium) is available from AAH, Phoenix and Movianto, in 5 presentations in packs of 10 prefilled syringes with active needle guard.

 

Trade contact:

sunils@intrapharmlabs.com

 

Trade orders:

Movianto

Tel:        01234 248632

Fax:       01234 248705

Email:  orders.UK@movianto.com

 

Basic NHS price for packsize 10 prefilled syringes with needle guard: 20mg/0.2ml – £16.69; 40mg/0.4ml -£24.22; 60mg/0.6ml -£31.41; 80mg/0.8ml -£44.10; 100mg/1ml -£57.84

Healthcare Professional ONLY
This website is intended for Healthcare professionals only

Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors